You're going to do well at 59c buys imo.
CYP have already had CMC discussions with FDA.
Our cells are exactly what they will be looking for.
Also note, recent CYP presentations now include KPI milestones for 2021 that include progressing US/FDA strategy so we'd be expecting some moves over the next 3-6 months here too to add to the multiple planned and existing trials lining up.
Add that to the fact this Cymerus highly scalable cell tech came out of one of their own prestigious research centres...and well known James Thomson/ Igor Sulkvin
https://stemcells.wisc.edu/staff/slukvin-igor-i/
-
- There are more pages in this discussion • 280 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
17.5¢ |
Change
0.010(6.06%) |
Mkt cap ! $39.54M | |||
| Open | High | Low | Value | Volume |
| 17.5¢ | 18.0¢ | 17.5¢ | $29.83K | 169.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 36293 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 2837 | 1 |
View Market Depth
| Last trade - 13.02pm 28/07/2025 (20 minute delay) ? |
| CYP (ASX) Chart |